DEC 19, 2018 05:12 PM PST

Bipolar Disorder? No Problem! Try Probiotics

In a recent study conducted at the American College of Neuropsychopharmacology, scientists have revealed the benefits of probiotics – good bacteria – and their positive influence on individuals diagnosed with bipolar disorder. To date, the most prevalent form of treatment is via psychotherapy and prescription medications such as mood stabilizers and antipsychotics.

In the United States, around 3 million individuals are diagnosed each year with bipolar disorder. Bipolar disorder is identified by severe changes in mood ranging from a state of depression to mania. In a recent publication, researchers discuss the emerging field of probiotic research and how it can impact the outcome of patients with bipolar disorder. Probiotics are non-pathogenic bacteria residing in the gut flora. Probiotics have been shown to increase the overall health of their host.

The study, led by Faith Dickerson in collaboration with colleagues at Baltimore Maryland’s Sheppard Pratt Health System, provides data supporting reduced inflammation of the gut after probiotic supplementations are administered. Inflammation of the intestine is a known trigger that exacerbates the effects of bipolar disorder.

The gastrointestinal (GI) tract and its function are strongly linked to the central nervous system; the relationship is known as the GBA or the gut-brain axis. This axis is the main terminal for communications between the endocrine, immune, and autonomic nervous systems. Studies have provided evidence that the GBA is highly influenced when the gut microbiome and the GI tract are off balance. Additionally, data exists revealing that allergies, autoimmune disorders, and psychiatric disorders are linked to the health of the bacteria residing in the gut.

Due to the swelling evidence of how inflammation impacts the effectiveness of the GBA, the researchers created a probiotic supplement to mitigate the inflammation caused by microbial imbalances in the gut. An experimental group of patients was observed over six months to determine the effects of the supplement. The patients were from a group of individuals recently hospitalized for mania. The scientists recorded changes in the patient’s mood and immune system over the duration.

Patients, given either the placebo supplement or the active probiotic, were monitored for baseline changes in their health and mood. The results display those receiving the developed probiotic supplement, on average, had fewer return visits to the hospital than those taking the placebo. The patients receiving the probiotics also did not require as much in-patient treatment. The scientists record that those with the best results were patients who, at first, had the highest inflammation. The team hopes that these results will begin to influence physicians’ decisions to incorporate the use of probiotics when treating individuals with bipolar disorder.

Sources: American College of Neuropsychopharmacology, Science Daily, YouTube

About the Author
You May Also Like
NOV 14, 2018
Immunology
NOV 14, 2018
Stress in Youth Can Mean Depression as an Adult
A research team investigates early life stress and its relation to adult depression and anxiety...
NOV 20, 2018
Immunology
NOV 20, 2018
Mutations Mutations Which Ones Do We Want?
A team at UCSF makes use of new SLICE tool to generate mutations that reveal specific genetic functions....
NOV 26, 2018
Health & Medicine
NOV 26, 2018
A New Test for Fibromyalgia
Anyone who has experienced severe, chronic pain knows the long process it takes to get a correct diagnosis. Many people see an average of 5-6 specialists b...
FEB 04, 2019
Immunology
FEB 04, 2019
Heating Up on the Flu
Climate change may affect the future of vaccinations and nutrition....
MAR 15, 2019
Health & Medicine
MAR 15, 2019
Tick-Borne Diseases Are Rapidly Rising in the U.S.
Tick-borne diseases have significantly increased in the U.S. in the past few years. In 2016 there were 48,610 reported cases and in 2017 59,349; these...
MAR 31, 2019
Drug Discovery
MAR 31, 2019
Glowing Tumors Reveal How Immunotherapeutics Work
In a study published in the Journal of Clinical Investigation, researchers used positron emission tomography (PET) scans to examine how an immunotherapy dr...
Loading Comments...